Iovance Biotherapeutics Inc (IOVA)
$8.48 -11.30% Close Oct 30, 2026 Live
Iovance Biotherapeutics stock today
Iovance Biotherapeutics closed at $8.48 on October 30, 2026, down 11.30% on the day. Over the past year it returned +334.9% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $3.79 billion.
$5.00$10.00$15.00
NovJan 2026MarMayJulSep
| Period | IOVA | S&P 500 (SPY) |
|---|---|---|
| 1 month | -42.8% | -0.9% |
| 3 months | +80.8% | +2.1% |
| Year to date | +210.6% | +11.7% |
| 1 year | +334.9% | +12.4% |
| 3 years | +129.2% | +88.5% |
| 5 years | -65.1% | +76.0% |
Key statistics
- Market value
- $3.79B
- Price / sales
- 11.7
- 52-week range
- $1.81 to $14.86
- Next report
- Nov 5, 2026
About Iovance Biotherapeutics
Iovance Biotherapeutics develops autologous tumor-infiltrating lymphocyte cell therapies for cancer treatment.
Sector: Health Care
More on Iovance Biotherapeutics
- Financials: revenue, earnings and segmentsRevenue +61% in the year to Dec 2025
- Returns: what $1,000 became$1,000 ten years ago is $1,357 today
No forecast, no recommendation. This page describes Iovance Biotherapeutics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.